Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03541668 |
| Consolidated Lead Sponsor | Tasly Biopharmaceuticals Co |
| Therapeutic Condition Cohort | Neurology, Psychiatry, and Pain |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 674 participants (ACTUAL) |
| Registered Start Date | 2018-05-18 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Xuanwu Hospital Capital Medical University | Beijing, China | Open Hospital Dossier -> |
| The First Hospital of Hebei Medical University | Shijiazhuang, China | Open Hospital Dossier -> |
| The Second Hospital of Hebei Medical University | Shijiazhuang, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.